Map the evidence architecture
Define module responsibilities, source documents, claims, datasets, and dependencies across the submission.
Book a Scoping Call FDA Premarket Approval
Premarket Approval writing support for high risk medical devices, including clinical modules, study reports, benefit risk narratives, and evidence integration.
The IMTS perspective
PMA documentation must support a reasonable assurance of safety and effectiveness through a complete, internally consistent body of scientific evidence. IMTS helps high risk device teams develop clinical and regulatory narratives across complex submission modules.
The volume of evidence is only one part of the challenge. FDA reviewers need a clear line from device design and proposed labeling through study methods, results, limitations, benefit risk conclusions, and postapproval considerations.
Scope of support
How we work
Define module responsibilities, source documents, claims, datasets, and dependencies across the submission.
Present study design, analyses, outcomes, limitations, and clinical meaning with precise source traceability.
Coordinate revisions and review responses so the evidence, labeling, and benefit risk position remain aligned.
Start a conversation
We will help define the scope, source materials, review process, and practical next step.
Book a Scoping Call